CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-20 | Levy Richard S Director | Purchase | +750 | $44.65 | $33K | 1,000 |
| 2020-03-20 | EHRLICH JASON See Remarks | Option exercise | +6,950 | $10.29 | $72K | 29,492 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −233 | $42.32 | $10K | 29,259 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −1,458 | $43.59 | $64K | 27,801 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −2,120 | $44.40 | $94K | 25,681 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −750 | $45.54 | $34K | 24,931 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −1,917 | $46.18 | $89K | 23,014 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −344 | $47.44 | $16K | 22,670 |
| 2020-03-20 | EHRLICH JASON See Remarks | Sale | −128 | $48.59 | $6K | 22,542 |
| 2020-03-20 | EHRLICH JASON See Remarks | Returned to the company · Stock Option (Right to Buy) | +6,950 | 416,975 | ||
| 2020-03-19 | Liang Hong SVP, Discovery Medicine | Sale | −1,954 | $38.89 | $76K | 140,212 |
| 2020-03-19 | Liang Hong SVP, Discovery Medicine | Sale | −2,046 | $39.99 | $82K | 138,166 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +1,542 | $36.69 | $57K | 970,597 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +17,058 | $36.69 | $626K | 10,587,141 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +563 | $37.75 | $21K | 971,160 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +6,237 | $37.75 | $235K | 10,593,378 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +828 | $38.38 | $32K | 971,988 |
| 2020-03-18 | BAKER BROS. ADVISORS LP Director | Purchase | +9,172 | $38.38 | $352K | 10,602,550 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +828 | $38.99 | $32K | 969,055 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +9,172 | $38.99 | $358K | 10,570,083 |
Page 32 of 37 · 722 trades